Φορτώνει......
CTLA-4 correlates with immune and clinical characteristics of glioma
BACKGROUND: CTLA-4 is a well-studied immune checkpoint protein that negatively regulates T cell-mediated immune responses. However, the expression of CTLA-4 in glioma and the effects of CTLA-4 on prognosis in patients with glioma have not yet been examined. METHODS: We investigated the protein level...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cancer Cell Int |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6945521/ https://ncbi.nlm.nih.gov/pubmed/31911758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-019-1085-6 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|